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Abstract
Background: Nitrogen-13 has a 10-min half-life which places time constraints on the
complexity of viable synthetic methods for its incorporation into PET imaging agents.
In exploring ways to overcome this limitation, we have used the Ugi reaction to
develop a rapid one-pot method for radiolabelling peptidic molecules using [13N]NH3
as a synthetic precursor.
Methods: Carrier-added [13N]NH3 (50 μL) was added to a solution of carboxylic acid,
aldehyde, and isocyanide in 2,2,2-TFE (200 μL). The mixture was heated in a microwave
synthesiser at 120 °C for 10 min. Reactions were analysed by radio-HPLC and radio-
LCMS. Isolation of the target 13N–labelled peptidic Ugi compound was achieved via
semi-preparative radio-HPLC as demonstrated for Ugi1.
Results: Radio-HPLC analysis of each reaction confirmed the formation of radioactive
products co-eluting with their respective reference standards with radiochemical yields
of the crude products ranging from 11% to 23%. Two cyclic γ-lactam structures were
also achieved via intra-molecular reactions. Additional radioactive by-products observed
in the radio-chromatogram were identified as 13N–labelled di-imines formed from the
reaction of [13N]NH3 with two isocyanide molecules. The desired
13N–labelled Ugi
product was isolated using semi-preparative HPLC.
Conclusion: We have developed a one-pot method that opens up new routes to
radiolabel complex, peptidic molecules with 13N using aqueous [13N]NH3 as a
synthetic precursor.
Keywords: PET chemistry, Nitrogen-13, [13N]ammonia, Multicomponent reaction,
Peptide, Ugi
Background
Nitrogen-13 (t1/2 = 9.97 min; 100% β
+ decay) is used clinically in the field of positron
emission tomography (PET). Compared to other cyclotron-produced positron emitters
such as 18F and 11C, 13N has been largely overlooked as a viable option for radiolabel-
ling as its short half-life poses challenges to the development of synthetic methods.
Despite its limited use, 13N offers many favourable attributes that may be complementary
to conventional 11C and 18F labelling: the ubiquity of nitrogen in endogenous molecules
and pharmaceuticals allows direct labelling of molecules of interest without interfering
with their biological activity, enabling study of authentic biogenic molecules, and the
short half-life offers the ability to repeat PET scans on the same individual within a short
time and without excessive radiation dose to the patient. Cyclotron-produced 13N is most
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commonly generated by the proton bombardment of [16O]H2O via the nuclear reaction
16O(p,α)13N to produce [13N]NH3 (Wieland et al., 1991), which is the only routinely-used
13N radiopharmaceutical (for myocardial perfusion imaging) but can also be a potentially
useful radiolabelling precursor (Kumata et al., 2010; Kumata et al., 2012; Gomez-Vallejo et
al., 2014).
Multi-component reactions are powerful tools in the efficient and rapid generation of
diverse libraries of compounds, and are particularly useful for high-throughput screening.
The four-component Ugi reaction combines a carboxylic acid, an amine (sometimes
ammonia), an aldehyde or ketone, and an isocyanide to create α-aminoacyl amide
derivatives - peptidomimetic structures with proven pharmaceutical application
(Domling & Ugi, 2000). Notably, the one-pot synthesis of the local anaesthetic Xylo-
cain and the subsequent development and marketing of at least 12 other anaesthetics
is based on this scaffold (Hulme & Gore, 2003). The Ugi reaction is therefore an at-
tractive method for the rapid radiolabelling of peptides with short-lived PET radio-
nuclides, useful in diagnosis, drug discovery and as a research tool in understanding
molecular mechanisms in vivo. Here we report the radiolabelling of α-aminoacyl
amide derivatives with 13N, via the four-component coupling (4-CC) Ugi synthesis,
using aqueous [13N]NH3 as a precursor.
Methods
General
Benzaldehyde (≥99%), levulinic acid (98%), p-toluic acid (98%), tert-butyl isocyanide
(98%) and trifluoroacetic acid (99%) were purchased from Sigma-Aldrich. Benzyl iso-
cyanide (98%) and 2,2,2-trifluoroethanol (99.8%) were purchased from Acros Organics.
1,1,3,3-tetramethylbutyl isocyanide and ammonia solution (28–30%) were purchased
from Merck KGaA. Acetic acid (~100%) was purchased from AnalaR. Methanol (HPLC
grade) was purchased from Fisher.
Reactions were carried out using a CEM Discover microwave synthesis unit.
1H–NMR and 13C–NMR spectra were obtained using a Bruker DRX 400 MHz spec-
trometer. Mass spectrometry was performed on an Agilent Technologies 6520
Accurate-Mass Q-TOF LC/MS connected to an Agilent Technologies1200 HPLC sys-
tem with UV detector and autosampler.
Radio-HPLC analysis was performed on an Agilent Technologies 1200 Series with
UV detector (254 nm) and Lablogic β + radio-detector using an Agilent Eclipse XDB-
C18 column (5 μm, 4.6 × 150 mm). The following mobile phase conditions were used:
solvent A: H2O + 0.1% TFA; solvent B: MeOH +0.1% TFA; time:%B 0:5, 1:5, 10:95, 18:5,
23:5. Flow rate was 1 mL/min.
Reference standard synthesis
For reference standard compounds 1–5, benzaldehyde (2 mmol), the respective carbox-
ylic acid (p-toluic acid (2, 4) or acetic acid (1, 3, 5), 2 mmol), the respective isocyanide
(tert-butyl isocyanide (4, 5), benzyl isocyanide (3) or 1,1,3,3-tetramethylbutyl isocyanide
(1, 2), 2 mmol) and ammonia (excess, ~ 3 mmol) were combined in 2,2,2-trifluoroetha-
nol (TFE, 2 mL) in a microwave tube. For reference standard compounds 6–7, levulinic
acid (2 mmol), the respective isocyanide (benzyl isocyanide (6) or tert-butyl isocyanide
Blower et al. EJNMMI Radiopharmacy and Chemistry  (2017) 2:16 Page 2 of 10
(7), 2 mmol) and ammonia (excess, ~ 3 mmol) were combined in TFE (2 mL) in a
microwave tube. The mixture was heated at 100 °C for 30 min in a microwave synthesis
unit. The reaction mixture was cooled to room temperature and the solvent was re-
moved under vacuum. The crude product was filtered and washed with ice-cold metha-
nol. The final product was isolated using semi-preparative HPLC and lyophilised.
Radiochemistry
[13N]NH3 production
Aqueous [13N]NH3 was produced on a CTI RDS 112 biomedical cyclotron via the
16O(p,α)13N nuclear reaction. The target contained 8 mL H2O with 5 mM ethanol.
Concentration of [13N]NH3 into a 1 mL volume was carried out using a weak cation
exchange Sep-Pak (Accell Plus CM Light, Waters.) and eluted with saline (0.9%, 1 mL).
Radiolabelling of 1–7
For radiolabelling of 1–5, benzaldehyde (48.5 μmol), the respective carboxylic acid
(p-toluic acid (2, 4) or acetic acid (1, 3, 5), 48.5 μmol), the respective isocyanide
(tert-butyl isocyanide (4, 5), benzyl isocyanide (3) or 1,1,3,3-tetramethylbutyl isocyanide
(1, 2), 48.5 μmol), ammonium hydroxide solution (28–30%, 10 μL, 148 μmol) and
[13N]NH3 (50 μL) were combined in 2,2,2-trifluoroethanol (200 μL) in a microwave tube.
For radiolabelling of 6–7, levulinic acid (48.5 μmol), the respective isocyanide (benzyl
isocyanide (6) or tert-butyl isocyanide (7), 48.5 μmol), ammonium hydroxide solution
(28–30%, 10 μL, 148 μmol) and [13N]NH3 (50 μL) were combined in 2,2,2-trifluor-
oethanol (200 μL) in a microwave tube. The mixture was heated at 120 °C for 10 min
in a microwave synthesis unit with stirring. The reaction mixture was cooled to room
temperature and analysed via radio-HPLC. The desired 13N–labelled Ugi product was
isolated using semi-preparative HPLC.
Results
Reference standard synthesis
Based on methods developed by Thompson et al. (Thompson & Chen, 2009), reference
standards 1–7 were successfully synthesised and isolated. LC/MS analysis of the crude
product mixtures confirmed the presence of the desired 4-CC products. Full character-
isation of the final isolated products can be found in the Additional file 1.
Radiochemistry
Radiosynthesis of 1–5 was achieved via the Ugi reaction by combining benzaldehyde,
the respective carboxylic acid and isocyanide, and carrier-added aqueous [13N]NH3
(Fig. 1). Radiosynthesis of cyclic γ-lactams 6–7 was achieved using an intra-molecular
Ugi reaction by combining the ketone and carboxylic acid in a single molecule – levulinic
acid - with the respective isocyanide, and carrier-added [13N]NH3 (Fig. 1). All reaction
mixtures were heated using a microwave synthesis unit. Synthesis of 1 was selected as the
model reaction for optimisation (Table 1). Initially, experiments were performed in a
range of solvents and heated at 100 °C for 15 min. The optimum solvent was found to be
TFE, affording radiochemical yields (RCY, based on radio-HPLC analysis of the crude
product) of 13%, performing better than MeCN (9%), while DMF afforded no yield
(Table 1, entries 1–3). Reaction time and temperature were varied, with little effect on
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Fig. 1 Synthesis of 13N–labelled α-aminoacyl amide derivatives (1–5) and γ-lactams (6–7)
Table 1 Reaction optimisation
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RCY (Table 1, entries 4–8). A reaction time of 10 min at a temperature of 120 °C was
found to give optimal RCY (Table 1, entry 7). However, halving the reaction time only
marginally reduced the RCY from 14% to 12%. Thus, taking into account radioactive
decay, a shorter reaction time of 5 min would ultimately give higher activity yield
(Table 1, entry 8), and would be more practically useful in a clinical scenario. The
RCY was found to have the greatest dependency on the amount of carrier ammonia
added. Increasing the amount of carrier ammonia from 5 μL (74 μmol) to 10 μL
(148 μmol) led to an increase in RCY from 14% to 23%, respectively (Table 1, entries
7 and 9). A further increase to 20 μL (296 μmol) resulted in a decrease in RCY to 16%
(Table 1, entry 10). Under no-carrier-added conditions, the desired labelled product
was not observed. Increasing the volume of the aqueous [13N]NH3 in the reaction
from 50 μL to 100 μL resulted in a significant decrease in RCY.
The established optimum conditions of 1 were applied to the radiosynthesis of a
small library of compounds. 13N–labelling of target structures 1–7 was confirmed by
the co-elution of the non-radioactive standards and radio-LC/MS analysis. The radio-
chemical yield of these compounds ranged from 11 to 23% (Table 2). The molar activity
of [13N]NH3 used in these experiments was 2.64 ± 0.12 GBq/μmol. In addition to the
target Ugi compound and un-reacted [13N]NH3, another unknown radiolabelled species
was observed (Fig. 2). However, semi-preparative HPLC could be used to isolate the de-
sired 13N–labelled Ugi product. To demonstrate this, isolation of 1 was carried out,
achieving 96% radiochemical purity (Fig. 3) and an activity yield between 4 and 6%
(based on 24 min preparation time).
To identify the radioactive by-products, analogous reactions using stable isotope la-
belling with 14N and 15N were carried out, followed by LC/MS analysis to establish a
molecular weight associated with the by-products. In each case, the molecular weight
corresponded to the combination of one [14/15N]NH3 molecule and two isocyanide
molecules, suggesting the formation of labelled di-imine structures (Fig. 4).
Discussion
Ammonia is rarely used as the amine component in the Ugi reaction, as it reportedly
leads to low yields and extensive by-product formation. A common by-product is the
six-component coupling (6-CC) product formed through participation of the solvent
(usually methanol) (Ackermann et al., 2012; Kazmaier & Hebach, 2003). Thompson et al.
synthesised a library of structures via the Ugi reaction using ammonia, and replacing
methanol with the less nucleophilic solvent TFE suppressed formation of the 6-CC prod-
uct in favour of the desired 4-CC product (Thompson & Chen, 2009). Therefore, in the
present study TFE was used for all reactions. Using this strategy, reference standards 1–7
were successfully synthesised. LC/MS analysis of the crude product mixtures confirmed
the presence of the desired 4-CC product, with no evidence for a 6-CC product.
The radiolabelling of structures 1–7 via the Ugi reaction using aqueous carrier-added
[13N]NH3 as a precursor was successful, with RCYs ranging from 11 to 23%. Under the
tested conditions, the reaction did not proceed in the absence of carrier-added ammo-
nia and the RCY varied significantly depending on the amount of carrier ammonia
added: reducing the amount of ammonia from 10 μL (2.9 equivalents) to near stoichio-
metric amounts (5 μL, 1.4 equivalents) reduced the RCY; increasing to 20 μL (6 equiva-
lents), also reduced the RCY. Therefore, 10 μL was selected for all subsequent
Blower et al. EJNMMI Radiopharmacy and Chemistry  (2017) 2:16 Page 5 of 10
reactions. We note that under these specific high temperature, closed vessel microwave
conditions, the amount of ammonia in the solution versus the gas phase (and thus un-
available for reaction) has not been quantified. The necessary addition of carrier ammo-
nia to this reaction mixture will inherently result in a tracer with low molar activity,
potentially preventing the targeting of low-abundance receptors. The detrimental effect
on the RCY upon increasing the volume of aqueous [13N]NH3 suggests this reaction
could be affected by the presence of water and may benefit from anhydrous conditions.
The use of microwave technology is often beneficial when rapid chemistry is re-
quired, particularly when using such short-lived isotopes as nitrogen-13. A limited
number of experiments using conventional heating methods showed the target product
could be obtained, but in lower RCY than that obtained using microwave heating. This
Table 2 Radiolabelling of a small library of 13N–labelled α-aminoacyl amide derivatives and γ-
lactams
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indicates that the use of microwave technology is indeed effective in this case (see
Additional file 1).
Despite the presence of un-reacted [13N]NH3 and radioactive by-products in the
crude reaction mixture, the desired 13N–labelled Ugi product could be easily isolated
using semi-preparative HPLC, as demonstrated for reaction 1. The UV chromatogram
of the final isolated product showed two major products co-eluting with the radioactive
product. These are likely to be the non-radioactive α-aminoacyl amide Ugi product,
and a structurally similar α-acyloxy amide, the product of the three-component coupling
Passerini reaction between the isocyanide, carboxylic acid and aldehyde (see Additional
file 1). This is consistent with our observations of the presence of the 3-component coup-
ling Passerini product in the LC/MS analysis of the crude reaction mixture during synthe-
sis of the non-radioactive reference standards, and in the analogous 15N reactions. The
radioactive by-products observed in the radio-chromatograms of all reactions 1–7 were
identified as 13N–labelled di-imines in which one [13N]NH3 molecule reacts with the elec-
trophilic carbon of two isocyanide molecules to form the 13N–labelled di-imine (Fig. 4).
Identification of these by-products further contributes to expanding the breadth of known
radiochemistry available for radiosynthesis with [13N]NH3. Derivatisation of R1 and R2
substituents via the isocyanide and carboxylic acid moieties bearing targeting groups such
as peptides, sugars or other functional groups, could enable rapid access to libraries of
functionalised 13N–labelled compounds. Furthermore, it may be possible to label mole-
cules of specific biological interest using this method, such as 1,4-benzodiazepine-2,5-
diones which have shown promise as anticonvulsant agents, opiate receptor antagonists
Fig. 2 HPLC chromatogram of the crude radiolabelled product (Table 1, entry 9). a Radioactivity (counts per
second); target compound 1 at Rt 11.58 min; unreacted [
13N]NH3 at Rt 1.82 min; unknown by-product at Rt
8.55 min. b UV absorption (254 nm) of reaction 1
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and as inhibitors of histone deacetylases which are linked to the pathogenesis of several
cancers (Hulme et al., 1998; Loudni et al., 2007).
Conclusion
The novel methodology presented here demonstrates an efficient strategy for quickly
obtaining libraries of diverse 13N–labelled peptidomimetics. The Ugi reaction has
been successfully adapted to radiolabel a library of α-aminoacyl amide derivatives and
γ-lactams with 13N from cyclotron-produced aqueous [13N]NH3 precursor in a one-
pot method. This is also the first report of radiosynthesis with 13N using microwave
Fig. 3 HPLC chromatogram of the isolated radiolabelled product 1. a Radioactivity (counts per second);
b UV absorption (254 nm)
Fig. 4 Structures of radiolabelled by-products formed from reaction of [13N]NH3 with two molecules of
a 1,1,3,3-tetramethylbutyl isocyanide; b tertbutyl isocyanide and c benzyl isocyanide
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heating technology. This work demonstrates that despite its short half-life, complex
molecules can be rapidly labelled with 13N and as such, 13N should be regarded as a
viable option for labelling peptides in the future.
Additional file
Additional file 1: Electronic Supplementary Information. (DOCX 77 kb)
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